Stock Events

Stock Events

Heron Therapeutics (AXD2.F) Q2 2024 Earnings

AXD2.F
May 7Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.14
-0.1
-0.06
-0.02

Details

Expected EPS
-0.06930825
Actual EPS
-0.018600000000000002
Surprise EPS
0.05
Surprise Percent
+73.16%

Description

⁨Heron Therapeutics⁩ (⁦AXD2.F⁩) has reported earnings of ⁦-0.018600000000000002⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts